Cancer Research Cancer Epigenetics  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 43, 3497-3503, August 1, 1983]
© 1983 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sauer, L. A.
Right arrow Articles by Dauchy, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sauer, L. A.
Right arrow Articles by Dauchy, R. T.

Ketone Body, Glucose, Lactic Acid, and Amino Acid Utilization by Tumors in Vivo in Fasted Rats1

Leonard A. Sauer2 and Robert T. Dauchy

Mary Imogene Bassett Hospital, Cooperstown, New York 13326

Arteriovenous differences for acetoacetate, ß-hydroxybutyrate, glucose, lactic acid, and glutamine and other amino acids were measured across Morris hepatomas 5123C, 7777, and 7288CTCF and Walker sarcocarcinoma 256 in vivo in rats fasted for 2 days. The acetoacetate and ß-hydroxybutyrate concentrations in arterial whole blood of fasted tumor-bearing rats were 0.52 ± 0.06 and 1.82 ± 0.19 mM (S.E., n = 38), respectively. Both ketone bodies were utilized by the tumors, and the rates of utilization were directly related to the rates of supply. The mean utilization rates for acetoacetate and ß-hydroxybutyrate were 13.9 ± 2.9 (range, 0 to 64; n = 30) and 24.7 ± 4.4 (range, 0 to 145; n = 38) nmol/min/g tumor wet weight, respectively. Eight of the tumors produced acetoacetate, presumably from utilized ß-hydroxybutyrate. An average of 52% of the acetoacetate and 30% of the ß-hydroxybutyrate carried in the arterial blood was removed during one pass through the tumors. The concentrations of glucose and glutamine in the arterial whole blood of fasted tumor-bearing rats (n = 38) were 6.55 ± 0.3 and 0.76 ± 0.02 mM, respectively; both of these substrates were utilized at rates that were directly proportional to the rates of supply. The mean rates of glucose and glutamine utilization for all tumors in fasted rats were 101 ± 11 (range, 3 to 313) and 8.2 ± 1.1 (range, 0 to 25.1) nmol/min/g tumor wet weight, respectively. Thirty-six % of the glucose and 25% of the glutamine supplied to the tumors was utilized. Comparison (by linear regression and analysis of covariance) of the rates of supply and utilization of glucose and glutamine in tumors growing in fasted versus fed rats indicated that these substrates are utilized more efficiently by tumors growing in fasted animals. Lactic acid was either produced or utilized, depending on the arterial whole-blood concentration. Production or utilization occurred, respectively, when the arterial lactate concentration was less or greater than 1 to 3 mM. The arterial whole-blood amino acids (except glutamine) were utilized at rates that ranged from 1 to 4 nmol/min/g tumor wet weight. The results indicate that energy production for tumor growth in fasted rats is supported, in part, by an increased availability of ketone bodies, by an increased efficiency of utilization of glucose and glutamine, and, under certain circumstances, by utilization of lactic acid.

1 Supported by Grant CA 27809 from the USPHS, NIH, and the Stephen C. Clark Research Fund of the Mary Imogene Bassett Hospital.

2 To whom requests for reprints should be addressed.

Received 1/28/83. Accepted 4/21/83.




This article has been cited by other articles:


Home page
Nutr Clin PractHome page
R. Siddiqui, D. Pandya, K. Harvey, and G. P. Zaloga
Nutrition Modulation of Cachexia/Proteolysis
Nutr Clin Pract, April 1, 2006; 21(2): 155 - 167.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Zhu, W. Jiang, J. N. McGinley, and H. J. Thompson
2-Deoxyglucose as an Energy Restriction Mimetic Agent: Effects on Mammary Carcinogenesis and on Mammary Tumor Cell Growth In vitro
Cancer Res., August 1, 2005; 65(15): 7023 - 7030.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. D. Shewchuk, V. E. Baracos, and C. J. Field
Dietary L-Glutamine Supplementation Reduces the Growth of the Morris Hepatoma 7777 in Exercise-Trained and Sedentary Rats
J. Nutr., January 1, 1997; 127(1): 158 - 166.
[Abstract] [Full Text]


Home page
JPEN J Parenter Enteral NutrHome page
T. Oka, K. Ohwada, M. Nagao, K. Kitazato, and Y. Kishino
Arginine-Enriched Solution Induces a Marked Increase in Muscle Glutamine Concentration and Enhances Muscle Protein Synthesis in Tumor-Bearing Rats
JPEN J Parenter Enteral Nutr, November 1, 1994; 18(6): 491 - 496.
[Abstract] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
M. L. Goodstein, W. J. Richtsmeier, and L. A. Sauer
The Effect of an Acute Fast on Human Head and Neck Carcinoma Xenograft: Growth Effects on an 'Isolated Tumor Vascular Pedicle' in the Nude Rat
Arch Otolaryngol Head Neck Surg, August 1, 1993; 119(8): 897 - 902.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1983 by the American Association for Cancer Research.